ICICI Securities Limited
Krishna Institute of Medical Sciences’ (KIMS) delivered robust performance in Q4FY25 with revenue/EBITDA/PAT surging 26%/29%/49%, respectively. Existing clusters of AP/ Telangana grew 19%/23% while EBITDA growth was much faster at 37%/34% YoY, respectively.
Krishna Institute of Medical Sciences Ltd. is trading at high day volume of 1.3M.
More from Krishna Institute of Medical Sciences Ltd.
Recommended